{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:02:52Z","timestamp":1789664572918,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jconrel.2022.01.021","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T17:55:01Z","timestamp":1642614901000},"page":"78-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Immunostimulation of tumor microenvironment by targeting tumor-associated macrophages with hypoxia-responsive nanocomplex for enhanced anti-tumor therapy"],"prefix":"10.1016","volume":"343","author":[{"given":"Yeoul","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junha","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurusamy","family":"Saravanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinseong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooseok","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Jong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.01.021_bb0005","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti\u2013PD-1 antibody in Cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0010","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti\u2013PD-L1 antibody in patients with advanced Cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0015","first-page":"69","article-title":"CAR-T cell therapy: current limitations and potential strategies, blood","volume":"11","author":"Sterner","year":"2021","journal-title":"Cancer J."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41419-018-0278-6","article-title":"CAR-T cells: the long and winding road to solid tumors","volume":"9","author":"D\u2019Aloia","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrc.2016.54","article-title":"The role of myeloid cells in cancer therapies","volume":"16","author":"Engblom","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0035","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.2217\/fon-2018-0669","article-title":"Prognostic impact of tumor-associated macrophage infiltration in esophageal cancer: a meta-analysis","volume":"15","author":"Li","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0040","first-page":"605","article-title":"Turning cold into hot: firing up the tumor microenvironment, trends","volume":"6","author":"Duan","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0045","first-page":"72","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy, signal transduction and targeted","volume":"6","author":"Tang","year":"2021","journal-title":"Therapy"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","article-title":"Targeting tumor-associated macrophages in Cancer","volume":"40","author":"Pathria","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050946","article-title":"Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0065","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0070","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.20082173","article-title":"Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1","volume":"206","author":"Kuang","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0075","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0080","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4049\/jimmunol.164.2.762","article-title":"Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages","volume":"164","author":"Sica","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0085","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0090","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20171440","article-title":"Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity","volume":"215","author":"Hoves","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0095","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1084\/jem.20171435","article-title":"Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity","volume":"215","author":"Perry","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature19834","article-title":"PI3K\u03b3 is a molecular switch that controls immune suppression","volume":"539","author":"Kaneda","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0110","first-page":"116","article-title":"Immunotherapeutic effects of intratumoral nanoplexed poly I:C, journal for immunotherapy of","volume":"7","author":"Aznar","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0115","article-title":"Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration, journal for immunotherapy of","volume":"8","author":"Sultan","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/ecp.11.5","article-title":"The pharmacokinetics of toll-like receptor agonists and the impact on the immune system","volume":"4","author":"Engel","year":"2011","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.imbio.2016.06.009","article-title":"Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword","volume":"222","author":"Dajon","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0130","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3389\/fimmu.2020.01412","article-title":"Arginine-based poly(I:C)-loaded Nanocomplexes for the polarization of macrophages toward M1-Antitumoral effectors","volume":"11","author":"Dacoba","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0135","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jconrel.2020.11.024","article-title":"Phenylboronic-acid-based nanocomplex as a feasible delivery platform of immune checkpoint inhibitor for potent cancer immunotherapy","volume":"330","author":"Lim","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.610533","article-title":"Tumor microenvironment-stimuli responsive nanoparticles for anticancer therapy","volume":"7","author":"Thomas","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0150","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0155","doi-asserted-by":"crossref","first-page":"2000834","DOI":"10.1002\/adhm.202000834","article-title":"Tumor microenvironment sensitive Nanocarriers for bioimaging and therapeutics","volume":"10","author":"Park","year":"2021","journal-title":"Adv. Healthcare Materials"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.biomaterials.2016.09.034","article-title":"Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment","volume":"112","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0165","first-page":"667","article-title":"Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumours, nature","volume":"1","author":"Li","year":"2017","journal-title":"Biomed. Eng."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0170","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/acsnano.8b07045","article-title":"Hypoxia-triggered transforming Immunomodulator for Cancer immunotherapy via Photodynamically enhanced antigen presentation of dendritic cell","volume":"13","author":"Im","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0175","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.1021\/acsami.0c22644","article-title":"Enzyme-triggered disassembly of polymeric micelles by controlled Depolymerization via Cascade cyclization for anticancer drug delivery","volume":"13","author":"Park","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0180","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","article-title":"Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth","volume":"94","author":"Maxwell","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41389-017-0011-9","article-title":"The hypoxic tumour microenvironment","volume":"7","author":"Petrova","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0190","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ijc.21422","article-title":"Macrophage migration and gene expression in response to tumor hypoxia","volume":"117","author":"Murdoch","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0195","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/0008-5472.CAN-13-1196","article-title":"Van Ginderachter, tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather Fine-Tunes the M2-like macrophage population","volume":"74","author":"Laoui","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0205","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1172\/JCI84427","article-title":"The impact of hypoxia on tumor-associated macrophages","volume":"126","author":"Henze","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0215","doi-asserted-by":"crossref","first-page":"15846","DOI":"10.1021\/ja105937q","article-title":"Hypoxia-sensitive fluorescent probes for in vivo real-time fluorescence imaging of acute ischemia","volume":"132","author":"Kiyose","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0220","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1002\/anie.201308368","article-title":"Hypoxia- targeted siRNA delivery","volume":"53","author":"Perche","year":"2014","journal-title":"Angewandte Chemie-International Edition"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0225","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0230","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1016\/S0040-4039(00)82209-1","article-title":"The preparation of N-carboxyanhydrides of \u03b1-amino acids using bis(trichloromethyl)carbonate","volume":"29","author":"Daly","year":"1988","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0235","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1039\/c3cc40661j","article-title":"Concise solid-phase synthesis of inverse poly(amidoamine) dendrons using AB2 building blocks","volume":"49","author":"Huang","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0240","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1021\/jo00362a044","article-title":"The tosylation of alcohols","volume":"51","author":"Kabalka","year":"1986","journal-title":"J. Organic Chem."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0245","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1038\/srep06064","article-title":"Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide","volume":"4","author":"Luo","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0250","doi-asserted-by":"crossref","first-page":"80521","DOI":"10.18632\/oncotarget.11825","article-title":"Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0255","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fonc.2012.00089","article-title":"Irradiation promotes an m2 macrophage phenotype in tumor hypoxia","volume":"2","author":"Chiang","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0260","first-page":"e50966","article-title":"Bone marrow-derived macrophage production","author":"Trouplin","year":"2013","journal-title":"J. Visualiz. Exp. : JoVE"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0265","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1021\/acs.biomac.6b00350","article-title":"Hypoxia-responsive Polymersomes for drug delivery to hypoxic pancreatic Cancer cells","volume":"17","author":"Kulkarni","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2022.01.021_bb0270","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1021\/acs.analchem.8b00554","article-title":"Azoreductase and target simultaneously activated fluorescent monitoring for cytochrome c release under hypoxia","volume":"90","author":"Tang","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2022.01.021_bb0275","first-page":"1","article-title":"Tumor-associated CD204-positive macrophage is a prognostic marker in clinical stage I lung adenocarcinoma","author":"Sun","year":"2018","journal-title":"Biomed. Res. Int."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922000359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922000359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:14:15Z","timestamp":1759162455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922000359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":55,"alternative-id":["S0168365922000359"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.021","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunostimulation of tumor microenvironment by targeting tumor-associated macrophages with hypoxia-responsive nanocomplex for enhanced anti-tumor therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}